NCT01509612

Additive Homeopathy in Cancer Patients

Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter Study Evaluating Quality of Life in Patients With Advanced Malignant Lung Tumors With or Without "add-on" Homeopathy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Medical University of Vienna · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The investigators aim to investigate the validity of their previous results in a randomized prospective, placebo-controlled, double-blind, multicenter controlled evaluation of questionnaires in patients with advanced malignant tumors. The investigators plan to compare the treatment outcome (quality of life and survival) in tumor patients, receiving standard or "add-on" homeopathic treatment. The null hypothesis is that "add-on" homeopathic treatment does not create a benefit for cancer patients. In addition the investigators evaluate survival time.

Detailed description

The EORTC-QLQ-C30, SF-36 as well as a VAS scale for subjective well-being will be filled out by the patients.

Conditions

• Malignant Tumors

Interventions

Type	Name	Description
DRUG	Additive classical homeopathy	Homeopathic remedies every 2 to 3 months
DRUG	Homeopathic Placebo globules	Homeopathic placebo globules every 2 to 3 months

Timeline

• Start date: 2012-02-01
• Primary completion: 2019-07-31
• Completion: 2019-07-31
• First posted: 2012-01-13
• Last updated: 2021-06-16
• Results posted: 2020-11-03

Locations

1 site across 1 country: Austria